Fluorine in PDB 6vkk: Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
Enzymatic activity of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
All present enzymatic activity of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib:
2.4.2.30;
Protein crystallography data
The structure of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib, PDB code: 6vkk
was solved by
J.D.Steffen,
J.M.Pascal,
with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:
Resolution Low / High (Å)
|
20.00 /
2.10
|
Space group
|
P 21 21 21
|
Cell size a, b, c (Å), α, β, γ (°)
|
104.267,
107.902,
142.845,
90.00,
90.00,
90.00
|
R / Rfree (%)
|
23.9 /
26.1
|
Fluorine Binding Sites:
The binding sites of Fluorine atom in the Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
(pdb code 6vkk). This binding sites where shown within
5.0 Angstroms radius around Fluorine atom.
In total 4 binding sites of Fluorine where determined in the
Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib, PDB code: 6vkk:
Jump to Fluorine binding site number:
1;
2;
3;
4;
Fluorine binding site 1 out
of 4 in 6vkk
Go back to
Fluorine Binding Sites List in 6vkk
Fluorine binding site 1 out
of 4 in the Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 1 of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
A:F1101
b:33.6
occ:1.00
|
F1
|
A:RPB1101
|
0.0
|
33.6
|
1.0
|
C2
|
A:RPB1101
|
1.4
|
32.9
|
1.0
|
C1
|
A:RPB1101
|
2.3
|
33.3
|
1.0
|
C3
|
A:RPB1101
|
2.3
|
32.9
|
1.0
|
O
|
A:PHE897
|
3.0
|
29.4
|
1.0
|
CB
|
A:ALA898
|
3.3
|
32.3
|
1.0
|
C
|
A:PHE897
|
3.3
|
30.0
|
1.0
|
N
|
A:ALA898
|
3.4
|
30.3
|
1.0
|
CA
|
A:ALA898
|
3.5
|
31.4
|
1.0
|
CE
|
A:LYS903
|
3.5
|
34.0
|
1.0
|
CB
|
A:GLU988
|
3.5
|
33.5
|
1.0
|
C6
|
A:RPB1101
|
3.6
|
33.0
|
1.0
|
C4
|
A:RPB1101
|
3.6
|
32.6
|
1.0
|
CD
|
A:LYS903
|
3.8
|
34.4
|
1.0
|
CG
|
A:LYS903
|
3.9
|
33.7
|
1.0
|
C5
|
A:RPB1101
|
4.1
|
32.3
|
1.0
|
CA
|
A:GLU988
|
4.2
|
33.4
|
1.0
|
NZ
|
A:LYS903
|
4.2
|
35.7
|
1.0
|
CA
|
A:PHE897
|
4.3
|
29.7
|
1.0
|
O
|
A:ASN987
|
4.3
|
36.1
|
1.0
|
N
|
A:PHE897
|
4.4
|
29.3
|
1.0
|
OE2
|
A:GLU988
|
4.5
|
34.2
|
1.0
|
CD
|
A:GLU988
|
4.7
|
34.7
|
1.0
|
CG
|
A:GLU988
|
4.8
|
34.2
|
1.0
|
OG
|
A:SER904
|
4.8
|
34.6
|
1.0
|
C7
|
A:RPB1101
|
4.8
|
31.9
|
1.0
|
CB
|
A:LYS903
|
4.8
|
34.2
|
1.0
|
N2
|
A:RPB1101
|
4.8
|
33.1
|
1.0
|
O1
|
A:RPB1101
|
4.9
|
31.6
|
1.0
|
C
|
A:TYR896
|
4.9
|
30.5
|
1.0
|
C
|
A:ALA898
|
5.0
|
32.0
|
1.0
|
|
Fluorine binding site 2 out
of 4 in 6vkk
Go back to
Fluorine Binding Sites List in 6vkk
Fluorine binding site 2 out
of 4 in the Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 2 of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
D:F1101
b:40.2
occ:1.00
|
F1
|
D:RPB1101
|
0.0
|
40.2
|
1.0
|
C2
|
D:RPB1101
|
1.4
|
39.6
|
1.0
|
C1
|
D:RPB1101
|
2.3
|
38.5
|
1.0
|
C3
|
D:RPB1101
|
2.3
|
39.1
|
1.0
|
O
|
D:PHE897
|
3.0
|
39.1
|
1.0
|
CB
|
D:ALA898
|
3.2
|
42.7
|
1.0
|
C
|
D:PHE897
|
3.2
|
38.9
|
1.0
|
N
|
D:ALA898
|
3.3
|
39.8
|
1.0
|
CA
|
D:ALA898
|
3.4
|
41.5
|
1.0
|
C6
|
D:RPB1101
|
3.6
|
38.8
|
1.0
|
CE
|
D:LYS903
|
3.6
|
46.9
|
1.0
|
C4
|
D:RPB1101
|
3.6
|
38.9
|
1.0
|
CG
|
D:GLU988
|
3.7
|
46.8
|
1.0
|
CD
|
D:LYS903
|
3.8
|
47.9
|
1.0
|
CG
|
D:LYS903
|
3.9
|
47.9
|
1.0
|
C5
|
D:RPB1101
|
4.1
|
38.9
|
1.0
|
CA
|
D:PHE897
|
4.2
|
37.6
|
1.0
|
NZ
|
D:LYS903
|
4.2
|
47.1
|
1.0
|
CA
|
D:GLU988
|
4.3
|
45.5
|
1.0
|
O
|
D:ASN987
|
4.3
|
45.5
|
1.0
|
N
|
D:PHE897
|
4.3
|
37.4
|
1.0
|
CB
|
D:GLU988
|
4.5
|
46.6
|
1.0
|
CD
|
D:GLU988
|
4.5
|
47.4
|
1.0
|
OE2
|
D:GLU988
|
4.5
|
47.2
|
1.0
|
OG
|
D:SER904
|
4.7
|
44.7
|
1.0
|
C7
|
D:RPB1101
|
4.8
|
39.3
|
1.0
|
CB
|
D:LYS903
|
4.8
|
49.5
|
1.0
|
N2
|
D:RPB1101
|
4.9
|
39.0
|
1.0
|
O1
|
D:RPB1101
|
4.9
|
40.2
|
1.0
|
C
|
D:TYR896
|
4.9
|
37.5
|
1.0
|
C
|
D:ALA898
|
4.9
|
42.3
|
1.0
|
|
Fluorine binding site 3 out
of 4 in 6vkk
Go back to
Fluorine Binding Sites List in 6vkk
Fluorine binding site 3 out
of 4 in the Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 3 of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
C:F1101
b:40.6
occ:1.00
|
F1
|
C:RPB1101
|
0.0
|
40.6
|
1.0
|
C2
|
C:RPB1101
|
1.4
|
38.9
|
1.0
|
C3
|
C:RPB1101
|
2.3
|
39.8
|
1.0
|
C1
|
C:RPB1101
|
2.3
|
39.5
|
1.0
|
O
|
C:PHE897
|
3.0
|
37.0
|
1.0
|
C
|
C:PHE897
|
3.3
|
37.5
|
1.0
|
CB
|
C:ALA898
|
3.3
|
40.9
|
1.0
|
N
|
C:ALA898
|
3.4
|
37.7
|
1.0
|
CA
|
C:ALA898
|
3.5
|
39.2
|
1.0
|
CE
|
C:LYS903
|
3.5
|
46.6
|
1.0
|
C6
|
C:RPB1101
|
3.6
|
39.7
|
1.0
|
CG
|
C:GLU988
|
3.6
|
46.2
|
1.0
|
C4
|
C:RPB1101
|
3.6
|
39.5
|
1.0
|
CD
|
C:LYS903
|
3.7
|
46.3
|
1.0
|
CG
|
C:LYS903
|
3.9
|
46.2
|
1.0
|
NZ
|
C:LYS903
|
4.1
|
46.5
|
1.0
|
C5
|
C:RPB1101
|
4.1
|
40.1
|
1.0
|
CA
|
C:GLU988
|
4.2
|
42.7
|
1.0
|
O
|
C:ASN987
|
4.2
|
44.3
|
1.0
|
CA
|
C:PHE897
|
4.2
|
37.0
|
1.0
|
CB
|
C:GLU988
|
4.3
|
45.4
|
1.0
|
N
|
C:PHE897
|
4.3
|
37.2
|
1.0
|
CD
|
C:GLU988
|
4.4
|
47.5
|
1.0
|
OE2
|
C:GLU988
|
4.4
|
48.9
|
1.0
|
C7
|
C:RPB1101
|
4.8
|
39.9
|
1.0
|
OG
|
C:SER904
|
4.9
|
42.3
|
1.0
|
N2
|
C:RPB1101
|
4.9
|
40.9
|
1.0
|
O1
|
C:RPB1101
|
4.9
|
39.2
|
1.0
|
CB
|
C:LYS903
|
4.9
|
46.6
|
1.0
|
C
|
C:TYR896
|
4.9
|
37.6
|
1.0
|
|
Fluorine binding site 4 out
of 4 in 6vkk
Go back to
Fluorine Binding Sites List in 6vkk
Fluorine binding site 4 out
of 4 in the Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib
Mono view
Stereo pair view
|
A full contact list of Fluorine with other atoms in the F binding
site number 4 of Crystal Structure of Human Parp-1 Cat Domain Bound to Inhibitor Rucaparib within 5.0Å range:
probe
|
atom
|
residue
|
distance (Å)
|
B
|
Occ
|
B:F1202
b:37.6
occ:1.00
|
F1
|
B:RPB1202
|
0.0
|
37.6
|
1.0
|
C2
|
B:RPB1202
|
1.4
|
35.6
|
1.0
|
C1
|
B:RPB1202
|
2.3
|
35.2
|
1.0
|
C3
|
B:RPB1202
|
2.3
|
34.8
|
1.0
|
O
|
B:PHE897
|
3.0
|
32.7
|
1.0
|
CB
|
B:ALA898
|
3.3
|
34.5
|
1.0
|
C
|
B:PHE897
|
3.3
|
32.6
|
1.0
|
N
|
B:ALA898
|
3.4
|
33.0
|
1.0
|
CA
|
B:ALA898
|
3.4
|
34.3
|
1.0
|
CE
|
B:LYS903
|
3.5
|
37.8
|
1.0
|
C6
|
B:RPB1202
|
3.6
|
36.2
|
1.0
|
C4
|
B:RPB1202
|
3.6
|
34.8
|
1.0
|
CD
|
B:LYS903
|
3.7
|
38.0
|
1.0
|
CG
|
B:GLU988
|
3.7
|
41.2
|
1.0
|
CG
|
B:LYS903
|
3.9
|
37.9
|
1.0
|
C5
|
B:RPB1202
|
4.1
|
35.2
|
1.0
|
NZ
|
B:LYS903
|
4.1
|
37.7
|
1.0
|
O
|
B:ASN987
|
4.2
|
38.5
|
1.0
|
CA
|
B:PHE897
|
4.3
|
31.5
|
1.0
|
CA
|
B:GLU988
|
4.3
|
38.3
|
1.0
|
N
|
B:PHE897
|
4.4
|
32.2
|
1.0
|
CB
|
B:GLU988
|
4.4
|
40.2
|
1.0
|
CD
|
B:GLU988
|
4.5
|
41.2
|
1.0
|
OE2
|
B:GLU988
|
4.5
|
41.8
|
1.0
|
OG
|
B:SER904
|
4.7
|
33.0
|
1.0
|
CB
|
B:LYS903
|
4.8
|
37.9
|
1.0
|
C7
|
B:RPB1202
|
4.8
|
34.8
|
1.0
|
N2
|
B:RPB1202
|
4.9
|
36.6
|
1.0
|
O1
|
B:RPB1202
|
4.9
|
34.7
|
1.0
|
C
|
B:TYR896
|
5.0
|
32.6
|
1.0
|
C
|
B:ALA898
|
5.0
|
34.5
|
1.0
|
|
Reference:
L.Zandarashvili,
M.F.Langelier,
U.K.Velagapudi,
M.A.Hancock,
J.D.Steffen,
R.Billur,
Z.M.Hannan,
A.J.Wicks,
D.B.Krastev,
S.J.Pettitt,
C.J.Lord,
T.T.Talele,
J.M.Pascal,
B.E.Black.
Structural Basis For Allosteric Parp-1 Retention on Dna Breaks. Science V. 368 2020.
ISSN: ESSN 1095-9203
PubMed: 32241924
DOI: 10.1126/SCIENCE.AAX6367
Page generated: Fri Aug 2 03:08:28 2024
|